Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CD.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.439EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.439EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.408EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.408EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.256EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.256EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Q.7 (Alpha)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Q.7 (Alpha)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.460EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.460EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.262EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.262EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XALEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XALEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBWEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBWEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.61 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.61 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-9785.9South Korea
BA.2.75.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.524EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.524EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.25.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XADEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XADEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XABEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XABEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CH.1.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used